Menu
Integra LifeSciences is a global leader in regenerative tissue technologies and neurosurgical solutions dedicated to limiting uncertainty for clinicians, so they can focus on providing the best patient care. Integra offers a comprehensive portfolio of high quality, leadership brands that include AmnioExcel®, Bactiseal®, CerebroFlo®, Certas® Plus, Codman®, CUSA®, DuraGen®, DuraSeal®, ICP Express®, Integra®, MatriStem UBMTM, MediHoney®, MicroFrance®, PriMatrix®, SurgiMend®, TCC-EZ®, and VersaTru®.
1100 Campus Road
Princeton, New Jersey 08540
Phone: 16092750500
www.integralife.com
NEW YORK, Oct. 2, 2023 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Integra LifeSciences Holdings Corporation (NASDAQ: IART) between March 11, 2019 and May 22, 2023, both dates inclusive (the "Class Period"), of the…
SAN FRANCISCO, Oct. 02, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges Integra LifeSciences Holdings Corp. (NASDAQ: IART) investors who suffered substantial losses to submit your losses now .
NEW YORK, Sept. 23, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Integra LifeSciences Holdings Corporation (NASDAQ: IART) between March 11, 2019 and May 22, 2023, both dates inclusive (the “Class Period”), of the important November 13, 2023 lead plaintiff deadline.
NEW YORK, Sept. 20, 2023 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP:
NEW YORK, Sept. 18, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of common stock of Integra LifeSciences Holdings Corporation (NASDAQ: IART) between March 11, 2019 and May 22, 2023, both dates inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than November 13, 2023.
SAN DIEGO, Sept. 18, 2023 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons or entities that purchased or otherwise acquired Integra Lifesciences Holdings Corporation (NASDAQ: IART) common stock between March 11, 2019 and May 22, 2023. Integra develops regenerative tissue technologies and neurological solutions.
Recent York, Recent York–(Newsfile Corp. – September 17, 2023) – WHY: Rosen Law Firm, a worldwide investor rights law firm, broadcasts the filing of a category motion lawsuit on behalf of purchasers of common stock of Integra LifeSciences Holdings Corporation (NASDAQ: IART) between March 11, 2019 and May 22, 2023, each dates inclusive (the “Class […] The post ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Integra LifeSciences Holdings Corporation Investors with Losses to Secure Counsel Before Essential Deadline in Securities Class Motion – IART appeared first on TodaysStocks.com .
New York, New York--(Newsfile Corp. - September 17, 2023) - WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of common…
Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they’ve untilNovember 13, 2023 to file lead plaintiff applications in a securities class motion lawsuit against Integra LifeSciences Holdings Corporation (NasdaqGS: IART), in the event that they purchased the Company’s shares between March 11, […] The post INTEGRA SHAREHOLDER ALERT by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors With Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Motion Lawsuit Against Integra LifeSciences Holdings Corporation – IART appeared first on TodaysStocks.com .